Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027

デジタル糖尿病管理の世界市場予測(~2027):製品別、装置種類別、エンドユーザー別

◆タイトル:Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027
◆商品コード:MD6871-22
◆調査・発行会社:MarketsandMarkets
◆発行日:2022年4月22日
◆ページ数:227
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥633,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥851,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,043,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のデジタル糖尿病管理市場規模が2022年143億ドルから2027年255億ドルまで、年平均12.2%成長すると予想しています。本市場調査資料では、デジタル糖尿病管理の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(装置、デジタル糖尿病管理アプリ、データ管理ソフトウェア・プラットフォーム、サービス)分析、種類別(ウェアラブル型装置、手持型装置)分析、エンドユーザー別(個人/在宅医療、病院・専門糖尿病クリニック、学術・研究機関)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のデジタル糖尿病管理市場規模:製品・サービス別(装置、デジタル糖尿病管理アプリ、データ管理ソフトウェア・プラットフォーム、サービス)
・世界のデジタル糖尿病管理市場規模:種類別(ウェアラブル型装置、手持型装置)
・世界のデジタル糖尿病管理市場規模:エンドユーザー別(個人/在宅医療、病院・専門糖尿病クリニック、学術・研究機関)
・世界のデジタル糖尿病管理市場規模:地域別
・競争状況
・企業情報

“The global digital diabetes management market is projected to reach USD 25.5 Billion by 2027 from an estimated USD 14.3 Billion in 2022, at a CAGR of 12.2% during the forecast period.”
The rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly flexible solutions in the market. The increasing adoption of cloud-based enterprise solutions and the growing use of connected devices and apps are some of the other major factors supporting market growth. However, factors such as the high device costs, lack of reimbursement in developing countries, and the higher acceptance of traditional diabetes management devices are expected to restrain the growth of this market during the forecast period.

“Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management market.”
The devices segment is categorized into smart glucose meters, CGM systems, smart insulin pens, and smart insulin pumps/closed-loop systems & smart insulin patches. In 2021, the smart glucose meters segment accounted for a share of 25.2% of the digital diabetes management devices market. The growth of this segment is mainly attributed to the easy handling of smart glucose meters, as well as their benefits in the early detection of hypo and hyperglycemic diabetes. Technological innovations, such as all-in-one glucometers with analysis capabilities, Bluetooth-enabled glucometers, and portable pocket-size glucometers are some of the other factors driving the growth of this market segment.

“Wearable devices segment to grow at the highest CAGR during the forecast period.”
Various devices considered in the digital diabetes management devices market are categorized into handheld devices and wearable devices. Wearable devices accounted for the largest share of 60.3% of the digital diabetes management devices market in 2021. This segment is estimated to grow at the highest CAGR of 13.2% during the forecast period. The increasing number of regulatory approvals for wearables, technological advancements, and the growing adoption of smart insulin pumps and insulin patches are driving the growth of the wearables market.

“The Self/home healthcare segment accounted for the largest share of Digital Diabetes Management market in 2021.”
The self/home healthcare segment accounted for the largest share of the digital diabetes management market in 2021. This is mainly attributed to the growing patient acceptability of home care due to the increasing awareness of digital diabetes management platforms. Self-administration is especially useful for patients who require regular insulin therapy. For patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents them from resuming a normal lifestyle.

“North America accounted for the largest share of the Digital Diabetes Management market in 2021.”
In 2021, North America accounted for the largest market share of 41.4%, followed by Europe with a share of 29.0%. North America dominates the digital diabetes management market, mainly due to the growing adoption of connected diabetes management devices, increasing adoption of diabetes management and obesity apps, growing demand for technologically advanced solutions, increased acceptance of digital diabetes solutions from payers, government initiatives to promote digital health, and rising awareness on self-diabetes management in the region.

A breakdown of the primary participants (supply-side) for the Digital Diabetes Management market referred to for this report is provided below:
• By Company Type: Tier 1–46%, Tier 2–33%, and Tier 3–21%
• By Designation: C-level–43%, Director Level–35%, and Others–22%
• By Region: North America–34%, Europe–26%, Asia Pacific–19%, Latin America- 11%, and Middle East and Africa– 10%

The prominent players operating in the global digital diabetes management market are Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care Holdings AG (Switzerland), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), One Drop (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Health2Sync (Taiwan), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Decide Clinical Software GmbH (Austria), Pendiq GmbH (Germany), and BeatO (India).

Research Coverage:
The market study covers the digital diabetes management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product & service, by device type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the digital diabetes management market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

【レポートの目次】

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
TABLE 1 STANDARD CURRENCY CONVERSION RATES 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 38
2.1.2 PRIMARY DATA 38
FIGURE 2 PRIMARY SOURCES 39
2.1.2.1 Key data from primary sources 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 42
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2021) 43
FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2021) 43
FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE DIGITAL DIABETES MANAGEMENT MARKET 45
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE DIGITAL DIABETES MANAGEMENT MARKET 45
FIGURE 10 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 11 DATA TRIANGULATION METHODOLOGY 47
2.4 MARKET SHARE ESTIMATION 48
2.5 ASSUMPTIONS FOR THE STUDY 48
3 EXECUTIVE SUMMARY 49
FIGURE 12 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 13 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION) 50
FIGURE 14 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 50
FIGURE 15 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 51
FIGURE 16 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 52
FIGURE 17 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT 52
4 PREMIUM INSIGHTS 54
4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW 54
FIGURE 18 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS ARE DRIVING MARKET GROWTH 54
4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 55
FIGURE 19 DEVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE ASIA PACIFIC MARKET 55
4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
FIGURE 20 THE US MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 56
4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET 57
FIGURE 21 NORTH AMERICAN MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 57
4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2022 VS. 2027 (USD MILLION) 57
FIGURE 22 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 59
5.2.1.1 Increasing prevalence of diabetes 59
TABLE 2 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS
(20–79 YEARS), 2021 VS. 2045 59
5.2.1.2 Technological advancements 59
5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management 60
5.2.1.4 Use of artificial intelligence in diabetes care devices 60
5.2.2 RESTRAINTS 61
5.2.2.1 High cost of devices and lack of reimbursement in developing countries 61
5.2.2.2 Higher acceptance of traditional diabetes management devices 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Increasing diabetes-related health expenditure 61
5.2.4 CHALLENGES 62
5.2.4.1 Low penetration in developing economies 62
5.2.4.2 Lack of data security 62
5.3 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 3 DIGITAL DIABETES MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.3.1 THREAT OF NEW ENTRANTS 63
5.3.2 THREAT OF SUBSTITUTES 64
5.3.3 BARGAINING POWER OF SUPPLIERS 64
5.3.4 BARGAINING POWER OF BUYERS 64
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.4 PATENT ANALYSIS 65
5.4.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT 65
5.4.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS 65
FIGURE 24 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2016–2021 65
5.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS 66
FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2016–2021 66
5.5 TECHNOLOGY ANALYSIS 66
5.6 AVERAGE SELLING PRICE TRENDS 67
TABLE 4 AVERAGE SELLING PRICE OF SMARTPHONE-CONNECTED INSULIN PUMPS, BY REGION, 2021 67
TABLE 5 AVERAGE SELLING PRICE OF SENSOR-BASED CONTINUOUS GLUCOSE MONITORS, BY REGION, 2021 67
5.7 VALUE CHAIN ANALYSIS 67
FIGURE 26 DIGITAL DIABETES MANAGEMENT MARKET: VALUE CHAIN ANALYSIS (2021) 68
5.8 ECOSYSTEM MAP 68
FIGURE 27 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM MAP (2021) 68
5.9 KEY CONFERENCES & EVENTS IN 2022–2023 69
TABLE 6 DIGITAL DIABETES MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.10 INDUSTRY TRENDS 69
5.10.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 69
TABLE 7 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 70
5.10.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS 70
TABLE 8 RECENT COLLABORATIONS IN THE DIGITAL DIABETES MANAGEMENT MARKET 71
5.10.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS 71
5.11 REGULATORY ANALYSIS 71
TABLE 9 INDICATIVE LIST OF REGULATORY AUTHORITIES 71
5.11.1 NORTH AMERICA 72
5.11.1.1 US 72
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 72
FIGURE 28 FDA 510(K) APPROVAL PROCESS 73
5.11.1.2 Canada 73
TABLE 11 CANADA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 73
5.11.2 EUROPE 74
FIGURE 29 CE MARK APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS 74
5.11.3 ASIA PACIFIC 74
5.11.3.1 Australia 74
5.11.3.2 Japan 75
TABLE 12 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 75
5.11.3.3 China 75
TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 75
5.11.3.4 India 75
5.11.4 LATIN AMERICA 76
5.12 REIMBURSEMENT SCENARIO 76
TABLE 14 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT 76
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 77
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 77
TABLE 15 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR TOP 3 APPLICATIONS (%) 77
5.13.2 BUYING CRITERIA 78
FIGURE 31 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 78
TABLE 16 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 78
5.14 ASSESSMENT OF COVID-19 IMPACT ON THE ECONOMIC SCENARIO IN THE DIGITAL DIABETES MANAGEMENT MARKET 78
6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE 80
6.1 INTRODUCTION 81
TABLE 17 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 81
6.2 DEVICES 81
TABLE 18 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 82
TABLE 19 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 82
6.2.1 SMART GLUCOSE METERS 83
6.2.1.1 Reducing prices and technological innovations to drive segment growth 83
TABLE 20 KEY SMART GLUCOSE METERS AVAILABLE IN THE MARKET 83
TABLE 21 SMART GLUCOSE METERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS 85
6.2.2.1 CGM segment to grow at the highest CAGR during the forecast period 85
TABLE 22 KEY CGM SYSTEMS AVAILABLE IN THE MARKET 86
TABLE 23 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.3 SMART INSULIN PENS 87
6.2.3.1 Increasing demand for personalized or patient-centric devices without needle-stick injuries to drive segment growth 87
TABLE 24 KEY SMART INSULIN PENS AVAILABLE IN THE MARKET 88
TABLE 25 SMART INSULIN PENS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES 89
6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive segment growth 89
TABLE 26 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES AVAILABLE IN THE MARKET 90
TABLE 27 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.3 DIGITAL DIABETES MANAGEMENT APPS 92
TABLE 28 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 92
TABLE 29 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 93
6.3.1 DIABETES & BLOOD GLUCOSE TRACKING APPS 93
6.3.1.1 Growing adoption of connected devices to drive segment growth 93
TABLE 30 KEY DIABETES & BLOOD GLUCOSE TRACKING APPS AVAILABLE IN THE MARKET 94
TABLE 31 DIABETES & BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
6.3.2 WEIGHT & DIET MANAGEMENT APPS 95
6.3.2.1 Growing obese population and the increasing need to prevent diabetes to drive segment growth 95
TABLE 32 KEY WEIGHT & DIET MANAGEMENT APPS AVAILABLE IN THE MARKET 96
TABLE 33 WEIGHT & DIET MANAGEMENT APPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 96
6.4 DATA MANAGEMENT SOFTWARE & PLATFORMS 97
6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE SEGMENT GROWTH 97
TABLE 34 KEY DATA MANAGEMENT SOFTWARE & PLATFORMS AVAILABLE IN THE MARKET 97
TABLE 35 DATA MANAGEMENT SOFTWARE & PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
6.5 SERVICES 99
6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE SEGMENT GROWTH 99
TABLE 36 KEY SERVICES AVAILABLE IN THE MARKET 99
TABLE 37 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 100
7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 38 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 102
7.2 WEARABLE DEVICES 102
7.2.1 WEARABLE DEVICES DOMINATE THE DIGITAL DIABETES MANAGEMENT DEVICES MARKET 102
TABLE 39 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
7.3 HANDHELD DEVICES 103
7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST SEGMENT GROWTH 103
TABLE 40 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER 105
8.1 INTRODUCTION 106
TABLE 41 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 106
8.2 SELF/HOME HEALTHCARE 106
8.2.1 HIGH COST OF INPATIENT CARE HAS FUELED THE PREFERENCE FOR SELF/HOME CARE 106
TABLE 42 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2020–2027 (USD MILLION) 107
8.3 HOSPITALS & SPECIALTY DIABETES CLINICS 107
8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST SEGMENT GROWTH 107
TABLE 43 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS & SPECIALTY DIABETES CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 108
8.4 ACADEMIC & RESEARCH INSTITUTES 108
8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE SEGMENT GROWTH 108
TABLE 44 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 109
9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION 110
9.1 INTRODUCTION 111
FIGURE 32 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS 111
TABLE 45 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION,
2020–2027 (USD MILLION) 111
9.2 NORTH AMERICA 112
FIGURE 33 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 112
TABLE 46 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 113
TABLE 49 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 51 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 114
9.2.1 US 115
9.2.1.1 Increasing diabetes prevalence and high penetration of digital platforms have boosted the growth of the US market 115
TABLE 52 US: MACROECONOMIC INDICATORS 115
TABLE 53 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 116
TABLE 54 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 116
TABLE 55 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 56 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 117
TABLE 57 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 117
9.2.2 CANADA 117
9.2.2.1 Favorable reimbursement scenario has contributed to the use of digital diabetes management in Canada 117
TABLE 58 CANADA: MACROECONOMIC INDICATORS 118
TABLE 59 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 118
TABLE 60 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 119
TABLE 61 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 119
TABLE 62 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 63 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 120
9.3 EUROPE 120
FIGURE 34 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 121
TABLE 64 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 122
TABLE 65 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 122
TABLE 66 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 122
TABLE 67 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 123
9.3.1 GERMANY 124
9.3.1.1 Germany accounted for the largest share of the European digital diabetes management market in 2021 124
TABLE 70 GERMANY: MACROECONOMIC INDICATORS 124
TABLE 71 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 125
TABLE 72 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 74 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 75 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 126
9.3.2 UK 126
9.3.2.1 Supportive government initiatives have contributed to the growth of the UK market 126
TABLE 76 UK: MACROECONOMIC INDICATORS 127
TABLE 77 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 127
TABLE 78 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 128
TABLE 80 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 128
TABLE 81 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 128
9.3.3 FRANCE 129
9.3.3.1 Affordability of healthcare in France has contributed to the adoption of digital solutions 129
TABLE 82 FRANCE: MACROECONOMIC INDICATORS 129
TABLE 83 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 130
TABLE 84 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 131
9.3.4 ITALY 131
9.3.4.1 Increasing prevalence of diabetes to provide growth opportunities for market players in Italy 131
TABLE 88 ITALY: MACROECONOMIC INDICATORS 132
TABLE 89 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 132
TABLE 90 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 133
TABLE 91 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 92 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 133
TABLE 93 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 134
9.3.5 SPAIN 134
9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth 134
TABLE 94 SPAIN: MACROECONOMIC INDICATORS 134
TABLE 95 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 135
TABLE 96 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 135
TABLE 97 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 136
TABLE 98 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 136
TABLE 99 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 136
9.3.6 REST OF EUROPE 136
TABLE 100 ROE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 137
TABLE 101 ROE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 137
TABLE 102 ROE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ROE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 104 ROE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 138
9.4 ASIA PACIFIC 139
FIGURE 35 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT 140
TABLE 105 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 140
TABLE 106 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 141
TABLE 107 APAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 141
TABLE 108 APAC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 APAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 142
TABLE 110 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 142
9.4.1 JAPAN 142
9.4.1.1 High acceptance of digital solutions for diabetes management driving market growth in Japan 142
TABLE 111 JAPAN: MACROECONOMIC INDICATORS 143
TABLE 112 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 143
TABLE 113 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 144
TABLE 114 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 115 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 145
9.4.2 CHINA 145
9.4.2.1 Rising awareness about self-diabetes management among geriatric population driving market growth in China 145
TABLE 117 CHINA: MACROECONOMIC INDICATORS 146
TABLE 118 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 146
TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 147
TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 147
TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 147
TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 148
9.4.3 INDIA 148
9.4.3.1 Growing burden of diabetes and increasing need to reduce rising healthcare costs have boosted the adoption of digital platforms 148
TABLE 123 INDIA: MACROECONOMIC INDICATORS 148
TABLE 124 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 125 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 149
TABLE 126 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 150
TABLE 127 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 150
TABLE 128 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 150
9.4.4 AUSTRALIA 151
9.4.4.1 Initiatives to help treat or manage diabetes-related problems to drive market growth in Australia 151
TABLE 129 AUSTRALIA: MACROECONOMIC INDICATORS 151
TABLE 130 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 151
TABLE 131 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 152
TABLE 132 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 133 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 134 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 153
9.4.5 REST OF ASIA PACIFIC 153
TABLE 135 ROAPAC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 153
TABLE 136 ROAPAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 154
TABLE 137 ROAPAC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 154
TABLE 138 ROAPAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 139 ROAPAC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 155
9.5 LATIN AMERICA 155
TABLE 140 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 141 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 156
TABLE 142 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 156
TABLE 143 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 144 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 145 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 157
9.5.1 BRAZIL 157
9.5.1.1 High private healthcare expenditure and increasing geriatric population driving market growth in Brazil 157
TABLE 146 BRAZIL: MACROECONOMIC INDICATORS 158
TABLE 147 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 158
TABLE 148 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 159
TABLE 149 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 159
TABLE 150 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 151 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 160
9.5.2 MEXICO 160
9.5.2.1 Growing obesity rate in Mexico to drive market growth 160
TABLE 152 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 160
TABLE 153 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 161
TABLE 154 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 155 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 156 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 162
9.5.3 REST OF LATIN AMERICA 162
TABLE 157 ROLATAM: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 162
TABLE 158 ROLATAM: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 163
TABLE 159 ROLATAM: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 163
TABLE 160 ROLATAM: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 161 ROLATAM: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 164
9.6 MIDDLE EAST & AFRICA 164
9.6.1 DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES HAS YET TO PICK UP PACE 164
TABLE 162 AFRICA: MACROECONOMIC INDICATORS 164
TABLE 163 MEA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 165
TABLE 164 MEA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 165
TABLE 165 MEA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 166 MEA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE,
2020–2027 (USD MILLION) 166
TABLE 167 MEA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 166
10 COMPETITIVE LANDSCAPE 167
10.1 OVERVIEW 167
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 167
FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET 168
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET 169
FIGURE 37 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN THE DIGITAL DIABETES MANAGEMENT MARKET 169
10.4 MARKET SHARE ANALYSIS 170
FIGURE 38 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES (2021) 170
FIGURE 39 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2021) 170
FIGURE 40 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2021) 171
FIGURE 41 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2021) 171
10.5 R&D ASSESSMENT OF KEY PLAYERS 172
FIGURE 42 R&D EXPENDITURE: KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET, 2019, 2020, AND 2021 172
10.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 173
FIGURE 43 GEOGRAPHIC REVENUE ASSESSMENT: DIGITAL DIABETES MANAGEMENT MARKET (2021) 173
10.7 COMPANY EVALUATION QUADRANT 173
FIGURE 44 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX, 2021 174
10.7.1 STARS 175
10.7.2 EMERGING LEADERS 175
10.7.3 PERVASIVE PLAYERS 175
10.7.4 PARTICIPANTS 175
10.8 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS 175
FIGURE 45 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UPS 176
10.8.1 PROGRESSIVE COMPANIES 176
10.8.2 DYNAMIC COMPANIES 176
10.8.3 STARTING BLOCKS 177
10.8.4 RESPONSIVE COMPANIES 177
10.9 COMPETITIVE BENCHMARKING 177
10.9.1 OVERALL COMPANY FOOTPRINT 177
TABLE 168 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 177
TABLE 169 COMPANY FOOTPRINT: BY PRODUCT & SERVICE (25 COMPANIES) 178
TABLE 170 COMPANY FOOTPRINT: BY DEVICE TYPE (25 COMPANIES) 179
TABLE 171 COMPANY FOOTPRINT: BY END USER (25 COMPANIES) 180
TABLE 172 COMPANY FOOTPRINT: BY REGION (25 COMPANIES) 181
10.10 COMPETITIVE SCENARIO 182
10.10.1 PRODUCT LAUNCHES 182
TABLE 173 PRODUCT LAUNCHES (2020–2022) 182
10.10.2 DEALS 183
TABLE 174 DEALS (2020–2021) 183
11 COMPANY PROFILES 184
11.1 KEY PLAYERS 184
(Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 MEDTRONIC PLC 184
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2021) 185
11.1.2 F. HOFFMANN-LA ROCHE 188
TABLE 176 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 188
FIGURE 47 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 189
11.1.3 DEXCOM, INC. 192
TABLE 177 DEXCOM, INC.: BUSINESS OVERVIEW 192
FIGURE 48 DEXCOM, INC.: COMPANY SNAPSHOT (2021) 192
11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG 195
TABLE 178 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW 195
11.1.5 ABBOTT LABORATORIES 197
TABLE 179 ABBOTT LABORATORIES: BUSINESS OVERVIEW 197
FIGURE 49 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 198
11.1.6 B. BRAUN MELSUNGEN AG 201
TABLE 180 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 201
FIGURE 50 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021) 202
11.1.7 TIDEPOOL 203
TABLE 181 TIDEPOOL: BUSINESS OVERVIEW 203
11.1.8 GLOOKO, INC. 204
TABLE 182 GLOOKO: BUSINESS OVERVIEW 204
11.1.9 LIFESCAN, INC. 206
TABLE 183 LIFESCAN, INC.: BUSINESS OVERVIEW 206
11.1.10 AGAMATRIX, INC. 208
TABLE 184 AGAMATRIX, INC.: BUSINESS OVERVIEW 208
11.1.11 TANDEM DIABETES CARE, INC. 209
TABLE 185 TANDEM DIABETES CARE: BUSINESS OVERVIEW 209
FIGURE 51 TANDEM DIABETES CARE: COMPANY SNAPSHOT (2021) 209
11.1.12 INSULET CORPORATION 211
TABLE 186 INSULET CORPORATION: BUSINESS OVERVIEW 211
FIGURE 52 INSULET CORPORATION: COMPANY SNAPSHOT (2021) 211
11.1.13 DARIOHEALTH CORPORATION 213
TABLE 187 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW 213
FIGURE 53 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2021) 213
11.1.14 ONE DROP 214
TABLE 188 ONE DROP: BUSINESS OVERVIEW 214
11.1.15 DOTTLI 215
TABLE 189 DOTTLI: BUSINESS OVERVIEW 215
11.1.16 YPSOMED HOLDING AG 216
TABLE 190 YPSOMED HOLDING AG: BUSINESS OVERVIEW 216
FIGURE 54 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2021) 216
11.1.17 ARKRAY, INC. 218
TABLE 191 ARKRAY, INC.: BUSINESS OVERVIEW 218
11.1.18 ACON LABORATORIES, INC. 219
TABLE 192 ACON LABORATORIES, INC.: BUSINESS OVERVIEW 219
11.1.19 CARE INNOVATIONS, LLC 220
TABLE 193 CARE INNOVATIONS, LLC: BUSINESS OVERVIEW 220
11.1.20 HEALTH2SYNC 221
TABLE 194 HEALTH2SYNC: BUSINESS OVERVIEW 221
11.1.21 EMPERRA GMBH E-HEALTH TECHNOLOGIES 222
TABLE 195 EMPERRA GMBH E-HEALTH TECHNOLOGIES: BUSINESS OVERVIEW 222
11.1.22 AZUMIO 223
TABLE 196 AZUMIO: BUSINESS OVERVIEW 223
11.1.23 DECIDE CLINICAL SOFTWARE GMBH 224
TABLE 197 DECIDE CLINICAL SOFTWARE GMBH: BUSINESS OVERVIEW 224
11.1.24 PENDIQ GMBH 225
TABLE 198 PENDIQ GMBH: BUSINESS OVERVIEW 225
11.1.25 BEATO 226
TABLE 199 BEATO: BUSINESS OVERVIEW 226
*Details on Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 227
12.1 DISCUSSION GUIDE 227
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
12.3 AVAILABLE CUSTOMIZATIONS 233
12.4 RELATED REPORTS 233
12.5 AUTHOR DETAILS 234



★調査レポート[デジタル糖尿病管理の世界市場予測(~2027):製品別、装置種類別、エンドユーザー別] ( Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027 / MD6871-22) 販売に関する免責事項
[デジタル糖尿病管理の世界市場予測(~2027):製品別、装置種類別、エンドユーザー別] ( Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) - Global Forecast to 2027 / MD6871-22) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆